. 
GEDEON RICHTER LTD
About
Gedeon Richter Ltd – one of our parent companies – is the largest pharmaceutical factory in Hungary. It was established by Mr. Gedeon Richter, a pharmacist in 1901. Mr. Richter is not only the founder of the company, but the establishment of his firm also marked the beginning of the development of the Hungarian pharmaceutical industry.
A vertically integrated firm, Gedeon Richter Ltd carries out research, development, manufacturing, and marketing of human finished drugs, active substances and intermediates. Production takes place at two sites in Hungary: Budapest and Dorog. The company also has production facilities abroad, in Russia, Romania, the Ukraine and India. The company has a product range covering several therapeutic areas. It manufactures about one hundred kinds of pharmaceuticals in more than 170 presentations. Among its products are original, generic and licensed preparations.
Richter has always ascribed great importance to offering reliable, modern products throughout the world. The company has a marketing network that spreads over five continents and has 19 representative offices and 41 commercial and marketing companies (including Medimpex West Indies Ltd. and Medimpex Jamaica Ltd.). It markets active ingredients and finished products in Hungary and more than a hundred other countries. More than 90% of the company’s annual turnover comes from exports.
Richter has a widely known brand name and well-established sales network in Hungary, Central Eastern Europe and the CIS countries. By the end of 2011 the Group had set up its medical sales representative and marketing network in Western Europe while in 2013 we started further expansion in Latin America in order to offer the company’s gynaecological products in this region as well. Acting under strategic cooperation contracts and long-term supply agreements, Richter delivers products to its partners in the United States.
Gedeon Richter Ltd’s products cover numerous therapeutic areas, with special emphasis on the production and development of drugs for the central nervous system, as well as antiulcer agents, cardiovascular and gastrointestinal preparations as well as oral contraceptives.